Advertisement

Topics

Roche’s Gazyvaro Is Fifth Drug To Enter UK Cancer Drugs Fund

00:55 EDT 28 Jul 2017 | Elsevier Business Intelligence

Roche’s Gazyvaro is the fifth drug to be recommended by UK HTA body NICE for use on an interim fund...   ...

Original Article: Roche’s Gazyvaro Is Fifth Drug To Enter UK Cancer Drugs Fund

NEXT ARTICLE

More From BioPortfolio on "Roche’s Gazyvaro Is Fifth Drug To Enter UK Cancer Drugs Fund"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...